Laiyun Wang's award-winning achievements

Two national invention patents. Rheumatism is called the second cancer in the world, and he solved this problem. After inspection, identification and clinical verification by senior experts from China Patent Office, he claimed that the product belongs to the world's first high-tech cutting-edge technology, and approved the national invention patent with the patent number of 34288. The patent won the gold medal in the 9th Invention Exhibition of Henan Province and the special gold medal in the 7th China Patent New Technology and New Products Expo, and was loaded into the computer network of experts with special characteristics in treating intractable diseases of the Ministry of Health. It has also been included in more than 30 books, such as China Dictionary of Practical Scientific and Technological Achievements, China Dictionary of Contemporary Inventors and China Excellent Patent Technology Selection, and reported by China Patent News, Science and Technology Daily, People's Daily (Market News) and Henan Science and Technology News. The Road to Health by china national radio and CCTV has been recommended to the whole country. Puyang county people's government awarded the title of advanced unit of scientific and technological work. Indications: Arthralgia such as rheumatism, rheumatoid paralysis, ankylosing spondylitis, hyperosteogeny, disc herniation, sciatica and vasculitis. The invented tracheitis rehabilitation liquid won the national invention patent (patent number: 96 1064056), and is mainly used for treating tracheitis, asthma and emphysema. Pure traditional Chinese medicine preparation has obvious curative effect and high cure rate. The medicine not only has strong functions of expelling evil spirits, sterilizing, eliminating phlegm, relieving cough and asthma, but also can enhance specific and nonspecific immune functions, thereby improving the body's ability to resist and expel evil spirits, improving the body's adaptability to internal and external environments, restoring disordered functions to normal, and reducing the number of colds. This patent has been published in more than 20 works, such as China Science and Technology Elite Ceremony, Selected Works of Applied Patent Technology in China, China Patent Newspaper and China Patent Bulletin, and has been announced to the whole country. This medicine can not only cure juvenile tracheitis, emphysema and asthma, but also cure them for decades.